Mexico · Delayed Price · Currency is MXN AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of MXN 7.15 trillion. The enterprise value is 8.34 trillion.
| Market Cap | 7.15T |
| Enterprise Value | 8.34T |
Important Dates
The last earnings date was Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | Oct 15, 2025 |
Share Statistics
| Current Share Class | 1.77B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 73.83% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 166.00 and the forward PE ratio is 16.06.
| PE Ratio | 166.00 |
| Forward PE | 16.06 |
| PS Ratio | 6.54 |
| PB Ratio | -2,824.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 193.66 |
| EV / Sales | 7.53 |
| EV / EBITDA | 15.58 |
| EV / EBIT | 22.19 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.45 |
| Debt / FCF | n/a |
| Interest Coverage | 6.22 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 17.12% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 19.89M |
| Profits Per Employee | 783,045 |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -13.48B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.99% in the last 52 weeks. The beta is 0.51, so AbbVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +2.99% |
| 50-Day Moving Average | 4,021.53 |
| 200-Day Moving Average | 3,776.74 |
| Relative Strength Index (RSI) | 45.18 |
| Average Volume (20 Days) | 974 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.39 |
Income Statement
In the last 12 months, AbbVie had revenue of MXN 1.09 trillion and earned 43.07 billion in profits. Earnings per share was 24.22.
| Revenue | 1.09T |
| Gross Profit | 778.94B |
| Operating Income | 371.39B |
| Pretax Income | 30.45B |
| Net Income | 43.07B |
| EBITDA | 522.75B |
| EBIT | 371.39B |
| Earnings Per Share (EPS) | 24.22 |
Balance Sheet
The company has 118.62 billion in cash and 1.29 trillion in debt, giving a net cash position of -1,176.07 billion.
| Cash & Cash Equivalents | 118.62B |
| Total Debt | 1.29T |
| Net Cash | -1,176.07B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -2.53B |
| Book Value Per Share | -1.90 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.20%, with operating and profit margins of 33.95% and 4.00%.
| Gross Margin | 71.20% |
| Operating Margin | 33.95% |
| Pretax Margin | 2.78% |
| Profit Margin | 4.00% |
| EBITDA Margin | 47.78% |
| EBIT Margin | 33.95% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 127.73, which amounts to a dividend yield of 3.04%.
| Dividend Per Share | 127.73 |
| Dividend Yield | 3.04% |
| Dividend Growth (YoY) | 16.85% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.04% |
| Earnings Yield | 0.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |